WOOD DALE, Ill., April 03, 2016 -- Dr. Jerry A. Iavarone offers a drug-free therapy called Interactive Metronome Therapy to improve attention, focus, and concentration in children and adults suffering from a number of conditions including ADHD and sensory processing issues. This therapy works to improve cognitive, behavioral, social and motor skills as well as sports performance. The computer-based technology used in this treatment encourages users to match computer-generated rhythms, thereby improving their internal sense of timing.
When the brain’s timing malfunctions due to a disconnection like Attention Deficit Hyperactivity Disorder (ADHD), sensory processing disorders, or learning disabilities, the physical, mental and emotional symptoms can be difficult to overcome.
Dr. Jerry Iavarone is trained in treating children with ADHD, Asperger’s, Sensory Processing Disorder, as well as other learning disabilities. By incorporating functional neurology and Interactive Metronome, Dr. Iavarone and his team treat patients who exhibit difficulties at school. For those who experience negative side effects of medication, especially for ADHD, this drug-free therapy offers an alternative to prescription medication.
Dr. Iavarone offers a unique treatment plan designed to fit each patient’s needs. The patient begins treatment with an initial assessment, which analyzes neurologic components such as primitive reflexes, eye movements, balance and brain timing. The results provide the framework for treatment and Interactive Metronome training.
“Not only can those with these disorders benefit from our services, we also help athletes improve their performance and those who have sustained concussions,” says Dr. Iavarone. “Brain timing is the essence of everything.” Athletes can benefit from brain timing to improve their focus and attention, ability to concentrate for long periods of time, block out distractions, increase their timing skills and remain engaged. Additionally, the treatment has shown to demonstrate improved rhythm, coordination and balance.
Interactive Metronome involves the principles of traditional musical metronome, combined with the precision of a highly advanced software platform, to create engaging interactive training exercises. The program records the patient’s timing at the millisecond level, providing instant results, which are essential in guiding improvement. This program uses a reference tone and guided sounds, along with hand and foot sensors to coordinate movements to computer-generated musical beats. Like training wheels on a bicycle, a patented auditory guidance system progressively challenges participants to improve their motor planning, sequencing and rhythmic timing performance. Dr. Iavarone develops a protocol specific for the individual and targets the hemisphere of the brain with deficiencies.
For more information about these services, contact Dr. Iavarone at (630) 766-1552.
About Dr. Jerry A. Iavarone
Dr. Jerry Iavarone is a Certified Chiropractic Sports Physician and Board Certified in Childhood Developmental Disorders. Dr. Iavarone offers a unique combination of treatment modalities that focuses on brain training and functional neurology to treat anxiety, depression, mood disorders, childhood developmental disorders, corporate decision making and sports performance.
Contact: Dr. Jerry A. Iavarone, (630) 766-1552


Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
FDA Approves Mitapivat for Anemia in Thalassemia Patients
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Italy Fines Apple €98.6 Million Over App Store Dominance 



